ABL Biotech to Raise $7M; Expands its R&D Facilities and Sets Up Clinical Research Organization in Singapore

Chennai: ABL Biotechnologies Ltd plans to raise $7 million (Rs 28 crore) through a GDR issue, according to information provided by the company to the stock exchange. Budget 2008-09 K.O. Isaac, Managing Director, ABL Biotechnologies Ltd, said the funds would be used to expand its R&D facilities here for drug discovery and to set up a clinical research organisation in Singapore.

MORE ON THIS TOPIC